Salem Investment Counselors’s Viemed Healthcare VMD Stock Holding History

Salem Investment Counselors’s Portfolio VMD Stock Details VMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$661K	Buy	57,982 +14,475	+33%	+$143K	0.02%	279
2026 Q1	$401K	Sell	43,507 -19,600	-31%	-$163K	0.01%	301
2025 Q4	$469K	Sell	63,107 -8,900	-12%	-$61K	0.01%	284
2025 Q3	$489K	Hold	72,007	–	–	0.01%	280
2025 Q2	$498K	Hold	72,007	–	–	0.02%	278
2025 Q1	$524K	Hold	72,007	–	–	0.02%	253
2024 Q4	$577K	Hold	72,007	–	–	0.02%	255
2024 Q3	$528K	Hold	72,007	–	–	0.02%	267
2024 Q2	$472K	Hold	72,007	–	–	0.02%	271
2024 Q1	$679K	Buy	72,007 +39,090	+119%	+$335K	0.02%	231
2023 Q4	$258K	Buy	32,917 +8,995	+38%	+$65.3K	0.01%	323
2023 Q3	$161K	Hold	23,922	–	–	0.01%	360
2023 Q2	$234K	Buy	23,922 +8,900	+59%	+$90.4K	0.01%	312
2023 Q1	$145K	Buy	15,022 +11,000	+273%	+$95.9K	0.01%	376
2022 Q4	$30.4K	Hold	4,022	–	–	﹤0.01%	593
2022 Q3	$24K	Buy	+4,022	New	+$25.8K	﹤0.01%	610
2021 Q1	–	Sell	-21,100	Closed	-$164K	–	925
2020 Q4	$164K	Buy	+21,100	New	+$186K	0.01%	296

Other funds holding VMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Forager Capital Management Birmingham, Alabama $266M AUM 40% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Salem Investment Counselors's VMD Position: Q2 2026 in Review

Salem Investment Counselors increased its Viemed Healthcare (VMD) stake by 33% in Q2 2026, buying an estimated $143K and bringing the position to 57,982 shares worth $661K. The position accounts for 0.02% of the portfolio, ranked #279.

Salem Investment Counselors first reported a position in VMD in Q4 2020 and has held it in 17 quarters since. The position peaked at $679K in Q1 2024. 166 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

Salem Investment Counselors held 57,982 shares of Viemed Healthcare worth $661K as of Q2 2026.
Salem Investment Counselors bought 14,475 Viemed Healthcare shares in Q2 2026, an estimated $143K.
Viemed Healthcare made up 0.02% of Salem Investment Counselors's portfolio in Q2 2026, its #279 holding.
Salem Investment Counselors first reported a position in Viemed Healthcare in Q4 2020 and has held it in 17 quarters since.
Salem Investment Counselors's Viemed Healthcare position peaked at $679K in Q1 2024.
166 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.